FDA Grants ‘Fast Track’ Approval for Artery Disease Treatment Developed in Israel

FDA Grants ‘Fast Track’ Approval for Artery Disease Treatment Developed in Israel


BioGenCell’s technology uses immune and stem cells from the patient’s own…

Continue Reading